Stay updated on Relamorelin in Diabetic Gastroparesis Clinical Trial
Sign up to get notified when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.

Latest updates to the Relamorelin in Diabetic Gastroparesis Clinical Trial page
- Check5 days agoChange DetectedA banner announces NIH’s transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. It appears above the study record page, which displays a 403 error.SummaryDifference1%

- Check12 days agoChange DetectedThe site footer revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check19 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision: v3.7.0 was added to the page. A broad set of terms and keywords related to the study and related conditions were removed from the page, and revision history metadata was updated.SummaryDifference17%

- Check61 days agoChange DetectedAn NIH grant/contract note for 2014 was added, and the site revision was updated to v3.6.6 (replacing the previous v3.6.5).SummaryDifference0.1%

- Check75 days agoChange DetectedThe changes data contains no additions or deletions for this page, so there is no text update to reflect on the study record. Consequently, no modifications to the study content are recorded.SummaryDifference0.0%

Stay in the know with updates to Relamorelin in Diabetic Gastroparesis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.